121 related articles for article (PubMed ID: 6937173)
1. The search for occult metastases in breast cancer: does it add to established staging methods?
Black RB; Roberts MM; Stewart HJ; Prescott R; Cant EL; Sumerling MD; Smith A; Forrest AP
Aust N Z J Surg; 1980 Dec; 50(6):574-9. PubMed ID: 6937173
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
4. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
[TBL] [Abstract][Full Text] [Related]
5. The evolution of the sentinel node procedure in the treatment of breast cancer.
Tvedskov TF
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
[TBL] [Abstract][Full Text] [Related]
6. FDG-PET for axillary lymph node staging in primary breast cancer.
Crippa F; Gerali A; Alessi A; Agresti R; Bombardieri E
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S97-102. PubMed ID: 15133635
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.
Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS
Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010
[TBL] [Abstract][Full Text] [Related]
8. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
[TBL] [Abstract][Full Text] [Related]
9. Axillary lymph node metastases in patients with small carcinomas of the breast: is accurate prediction possible?
Anan K; Mitsuyama S; Tamae K; Nishihara K; Iwashita T; Abe Y; Ihara T; Toyoshima S
Eur J Surg; 2000 Aug; 166(8):610-5. PubMed ID: 11003428
[TBL] [Abstract][Full Text] [Related]
10. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
[TBL] [Abstract][Full Text] [Related]
11. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
12. Is the investigation of patients with breast cancer for occult metastatic disease worth while?
Forrest AP; Cant EL; Roberts MM; Stewart HJ; Sumerling MD; Donaldson AA; Smith AF; Shivas AA
Br J Surg; 1979 Oct; 66(10):749-51. PubMed ID: 509053
[No Abstract] [Full Text] [Related]
13. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
14. Influence of tumor histology on preoperative staging accuracy of breast metastases to the axilla.
Hackney L; Williams S; Bajwa S; Morley-Davies AJ; Kirby RM; Britton I
Breast J; 2013; 19(1):49-55. PubMed ID: 23186153
[TBL] [Abstract][Full Text] [Related]
15. The significance of extracapsular extension of axillary lymph node metastases in early-stage breast cancer.
Hetelekidis S; Schnitt SJ; Silver B; Manola J; Bornstein BA; Nixon AJ; Recht A; Gelman R; Harris JR; Connolly JL
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):31-4. PubMed ID: 10656369
[TBL] [Abstract][Full Text] [Related]
16. Predicting axillary sentinel node status in patients with primary breast cancer.
Kolarik D; Pecha V; Skovajsova M; Zahumensky J; Trnkova M; Petruzelka L; Halaska M; Sottner O; Otcenasek M; Kolarova H
Neoplasma; 2013; 60(3):334-42. PubMed ID: 23374005
[TBL] [Abstract][Full Text] [Related]
17. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study.
Dowlatshahi K; Fan M; Bloom KJ; Spitz DJ; Patel S; Snider HC
Cancer; 1999 Sep; 86(6):990-6. PubMed ID: 10491525
[TBL] [Abstract][Full Text] [Related]
18. Second axillary sentinel node biopsy for ipsilateral breast tumour recurrence.
Intra M; Trifirò G; Galimberti V; Gentilini O; Rotmensz N; Veronesi P
Br J Surg; 2007 Oct; 94(10):1216-9. PubMed ID: 17583891
[TBL] [Abstract][Full Text] [Related]
19. The Sentinel Node with Isolated Breast Tumor Cells or Micrometastases. Benefits and Risks of Axillary Dissection.
Madekivi V; Boström P; Aaltonen R; Vahlberg T; Salminen E
Anticancer Res; 2017 Jul; 37(7):3757-3762. PubMed ID: 28668871
[TBL] [Abstract][Full Text] [Related]
20. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]